Trial Profile
Impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes: an open label, randomised active-comparator trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LYDIA
- 01 Jun 2021 Results of pre-specified secondary analysis of this trial was published in the Diabetes, Obesity and Metabolism.
- 01 Jul 2020 According to a results published in the Diabetes, Obesity and Metabolism, the study was supported by the NIHR Leicester Biomedical Research Center (BRC), the NIHR CLAHRC-East Midlands, the NIHR Leicester Clinical Research Facility and The NIHR Leicester Clinical Trial Unit (CTU).
- 03 May 2018 Status changed from recruiting to completed.